Cewkowo-środmiąższowe zapalenie nerek u chorej przewlekle zażywającej furosemid
 
Więcej
Ukryj
1
Klinika Chorób Wewnętrznych i Metabolicznych SUM w Katowicach
AUTOR DO KORESPONDENCJI
Anna Bekier-Żelawska   

Klinika Chorób Wewnętrznych i Metabolicznych SUM, 40-635 Katowice, ul. Ziołowa 45/47; tel. 032 359 83 00 fax. 032 252 35 93
 
Ann. Acad. Med. Siles. 2009;63:81–85
 
SŁOWA KLUCZOWE
STRESZCZENIE
W przedstawionej pracy omówiono przypadek cewkowo-śródmiąższowego zapalenia oraz wapnicy nerek u chorej długotrwale zażywającej diuretyk pętlowy (furosemid). Powikłania przewlekłej terapii furosemidem, prowadzące do zaburzeń gospodarki wapniowej, skutkują m.in. powstawaniem kamicy i wapnicy nerek . Leczeniem z wyboru, w uzasadnionych przypadkach, jest całkowite odstawienie leku moczopędnego.
ISSN 0208-5607
 
REFERENCJE (23)
1.
Albright F, Baird PC, Cope O, Bloomberg E. Studies on the physiology of the parathyroid glands. IV. Renal complications of hyperparathyroidism. Am J Med Sci. 1934;187(1):49-65.
 
2.
Tykarski A. Manitius J. Diuretyki w leczeniu nadciśnienia tętniczego i chorób nerek Gdańsk 2006. Wydanie I.
 
3.
Hufnagle KG, Khan SN, Penn D, et al. Renal calcifi cations: A complication of long-term furosemide therapy in pre-term infants. Pediatrics 1982 Sep; 70(3):360-3.
 
4.
Kim YG, Kim B, Kim MK, Chung SJ, Han HJ, Ryu JA, Lee YH i wsp. Medullary nephrocalcinosis associated with long-term furosemide abuse in adults. Nephrol Dial Transplant. 2001 Dec;16(12):2303-9.
 
5.
Jennings M, Shortland JR, Maddocks JL. Interstitial nephritis associated with frusemide. J R Soc Med. 1986 Apr;79(4):239-40.
 
6.
Park CW, You HY, Kim YK, Chang YS, Shin YS, Hong CK, Kim YC, Bang BK. Chronic tubulointerstitial nephritis and distal renal tubular acidosis in a patient with frusemide abuse. Nephrol Dial Transplant. 2001 Apr;16(4):867-9.
 
7.
Pattaragarn A, Fox J, Alon US. Eff ect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat. Kidney International (2004) 65, 1684–1689.
 
8.
Pressler CA, Heinzinger J, Jeck N, Waldegger P, Pechmann U, Reinalter S, Konrad M i wsp. Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl- co-transporter. J Am Soc Nephrol. 2006 Aug;17(8):2136-42.
 
9.
Balogun RA, Adams ND, Palmisano J, et al. Focal segmental glomerulosclerosis, proteinuria and nephrocalcinosis associated with renal tubular acidosis. Nephrol Dial Transplant. Feb 2002;17(2):308-10.
 
10.
Saarela T, Lanning P, Koivisto M, Paavilainen T. Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up. Eur J Pediatr. 1999 Aug;158(8):668-72.
 
11.
Solivetti FM, Paganelli C, Zoff oli M, Bacaro D, Quintigliano D, Nasrollah N. Nephrocalcinosis induced by long-term therapy with furosemide. J Clin Ultrasound. 1997 Nov-Dec;25(9):519-20.
 
12.
Alon US. Nephrocalcinosis. Curr Opin Pediatr. 1997 Apr;9(2):160-5. Review.
 
13.
Kugelman A, Durand M, Garg M. Pulmonary eff ect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia. Pediatrics. 1997 Jan;99(1):71-5.
 
14.
Pope JC 4th, Trusler LA, Klein AM, Walsh WF, Yared A, Brock JW. The natural history of nephrocalcinosis in premature infants treated with loop diuretics. 3rd.J Urol. 1996 Aug;156(2 Pt 2):709-12.
 
15.
Alon US, Kaplan RA, Gratny LL, Nichols MA. Histological long-term outcome of furosemide-induced nephrocalcinosis in the young rat. Pediatr Nephrol. 1996 Apr;10(2):191-4.
 
16.
Alon US, Scagliotti D, Garola RE. Nephrocalcinosis and nephrolithiasis in infants with congestive heart failure treated with furosemide. J Pediatr. 1994 Jul;125(1):149-51.
 
17.
Kenney IJ, Aiken CG, Lenney W. Frusemide-induced nephrocalcinosis in very low birth weight infants. Pediatr Radiol. 1988;18(4):323-5.
 
18.
Myracle MR, McGahan JP, Goetzman BW, Adelman RD. Ultrasound diagnosis of renal calcifi cation in infants on chronic furosemide therapy J Clin Ultrasound. 1986 May;14(4):281-7.
 
19.
Tajiri J, Nakayama M, Sato T, Isozaki S, Uchino K. Pseudo-Bartter’s syndrome due to furosemide abuse: report of a case and an analytical review of Japanese literature. Jpn J Med. 1981 Jul;20(3):216-21.
 
20.
Lin MT, Tsau YK, Tsai WY, Tsai WS, Lu FL, Hsiao PH, Chen CH. Nephrocalcinosis in childhood. Acta Paediatr Taiwan. 1999 Jan-Feb;40(1):27-30.
 
21.
Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, Vargas-Poussou R, Lakings A I wsp. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol. 2000 Aug;11(8):1449-59.
 
22.
Karolina Kędzierska, Kazimierz Ciechanowski, Maria Pietrzak-Nowacka. Pseudo-Gitelman’s syndrome as a consequence of loop diuretics abuse. Polskie Archiwum Medycyny Wewnętrznej 2001, 105(6), s.501-504.
 
23.
Kurschat C, Heering P, Grabensee B. Gitelman’s syndrome: an important diff erential diagnosis of hypokalemia Dtsch Med Wochenschr. 2003 May 30;128(22):1225-8.
 
eISSN:1734-025X